Under the restructuring exercise, the company will first abolish its ‘recognized business undertaking’ in Apollo Healthtec. Subsequently, both AHL and Kimmed Private Limited will be merged into Apollo HealthTake, unifying complex operations under a single roof.
Through this step, AAL aimed at unalwing the value by strategic reorganization, to enable its OMNI channel pharmacy and digital health business direct list, a company filing at an exchanges.
The company filing added, “A combined plan plans to earn Rs 25,000 crore through fiscal year 25,000 crore, with a huge Omni channel pharmacy distribution in India and a revenue of Rs 16,300 crore (US $ 1.9bn) in FY 25,” the company filing.
Following this transaction, Apollo HealthTech Limited will search for its equity shares list on NSE and BSE, paving investors directly to participate in the restoring organized entity.
In addition, Apollo disclosed a signed agreement on June 30, 2025 between AHL’s current shareholder and AHL promoter Shobe Kamini, on June 30, 2025. Rasmeli agreed to organize interests and share with the promoter and main employees, to organize interests and to share it with a beneficial operation.
Direct Shareholding AAL Shareholders in a Joint Entity. For every 100 stocks of AAL, AALL shareholders will receive 195.2 shares of the new entity. The company filing said the list of entity is expected in 18-21 months.
Commenting on development, Sunita Reddy, Managing Director of Apollo Hospitals Enterprise, said, “This widespread integrated network with this extensive digital layer will allow us to create a magnitude effect of magnitude than a single format of care. Directly enables con-con-checking, Kon-Chancellor holding and KO CO-CHEC.
Meanwhile, Aale will continue his attention to the healthcare delivery, he added.
(Disclaimer: The recommendations, suggestions, opinions and views given by experts are their own. This does not represent the views of the economic time)
(Now you can subscribe to our Etmarkets WhatsApp channel)
